270 related articles for article (PubMed ID: 25563682)
1. [Clopidogrel resistance in cerebrovascular disease -- results of one-year follow-up].
Szapáry L; Koltai K; Tibold A; Fehér A; Harang G; Pusch G; Fehér G
Orv Hetil; 2015 Jan; 156(2):53-9. PubMed ID: 25563682
[TBL] [Abstract][Full Text] [Related]
2. Secondary Stroke Prophylaxis with Clopidogrel Produces Sufficient Antiplatelet Response.
Rath CL; Jørgensen NR; Wienecke T
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2683-2690. PubMed ID: 29945766
[TBL] [Abstract][Full Text] [Related]
3. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
4. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
[TBL] [Abstract][Full Text] [Related]
5. Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.
Lu M
Pak J Pharm Sci; 2017 Jan; 30(1):217-221. PubMed ID: 28603135
[TBL] [Abstract][Full Text] [Related]
6. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
[TBL] [Abstract][Full Text] [Related]
7. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.
Hacke W
Cerebrovasc Dis; 2002; 13 Suppl 1():22-6. PubMed ID: 11803184
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial.
Li J; Zhao X; Meng X; Lin J; Liu L; Wang C; Wang A; Wang Y; Wang Y;
Stroke; 2016 Aug; 47(8):2025-30. PubMed ID: 27328699
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
[TBL] [Abstract][Full Text] [Related]
13. Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.
Lundström A; Laska AC; Von Arbin M; Jörneskog G; Wallén H
Platelets; 2014; 25(2):102-10. PubMed ID: 23527528
[TBL] [Abstract][Full Text] [Related]
14. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data.
Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ
Cerebrovasc Dis; 2004; 17(2-3):253-61. PubMed ID: 14981346
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
17. Profile and prevalence of clopidogrel resistance in patients of acute coronary syndrome.
Kumar S; Saran RK; Puri A; Gupta N; Sethi R; Surin WR; Dikshit M; Dwivedi SK; Narain VS; Puri VK
Indian Heart J; 2007; 59(2):152-6. PubMed ID: 19122249
[TBL] [Abstract][Full Text] [Related]
18. Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke/TIA?: No.
Hankey GJ
J Thromb Haemost; 2005 Jun; 3(6):1137-40. PubMed ID: 15946198
[No Abstract] [Full Text] [Related]
19. Clopidogrel with aspirin versus aspirin alone in prevention of stroke following transient ischemic attack or acute minor stroke.
Seadon S; Lang E
CJEM; 2015 May; 17(3):315-7. PubMed ID: 26034917
[TBL] [Abstract][Full Text] [Related]
20. Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study.
Rosafio F; Lelli N; Mimmi S; Vandelli L; Bigliardi G; Dell'Acqua ML; Picchetto L; Pentore R; Ferraro D; Trenti T; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1864-1873. PubMed ID: 28576652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
